These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2837911)

  • 1. Atrial natriuretic peptide regulates release of Na+-K+-ATPase inhibitor from rat brain.
    Crabos M; Ausiello DA; Haupert GT; Cantiello HF
    Am J Physiol; 1988 Jun; 254(6 Pt 2):F912-7. PubMed ID: 2837911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ouabainlike factor in Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat hypothalamic extract inhibits vasopressin-stimulated Na+-K+-ATPase activity in the rat renal medulla.
    Pippard C; Baylis PH
    Cell Biochem Funct; 1986 Jan; 4(1):25-9. PubMed ID: 3002655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaliuretic peptide: the most potent inhibitor of Na(+)-K+ ATPase of the atrial natriuretic peptides.
    Chiou S; Vesely DL
    Endocrinology; 1995 May; 136(5):2033-9. PubMed ID: 7720651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothalamic factor inhibits the (Na,K)ATPase from the extracellular surface. Mechanism of inhibition.
    Carilli CT; Berne M; Cantley LC; Haupert GT
    J Biol Chem; 1985 Jan; 260(2):1027-31. PubMed ID: 2981828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing effect of atrial natriuretic factor on Na, K-ATPase activity in rat kidney.
    Górny D; Korzeniowska J; Marciniak A; Pielecki J
    J Physiol Pharmacol; 1994 Mar; 45(1):173-81. PubMed ID: 8043906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANP differentially modulates marinobufagenin-induced sodium pump inhibition in kidney and aorta.
    Fedorova OV; Agalakova NI; Morrell CH; Lakatta EG; Bagrov AY
    Hypertension; 2006 Dec; 48(6):1160-8. PubMed ID: 17043158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Na+ pump in renal tubular cells is regulated by endogenous Na+-K+-ATPase inhibitor from hypothalamus.
    Cantiello HF; Chen E; Ray S; Haupert GT
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F574-80. PubMed ID: 2845805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase.
    Scavone C; Scanlon C; McKee M; Nathanson JA
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1036-43. PubMed ID: 7891313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of atrial natriuretic peptide secretion and synthesis by Na-K-ATPase inhibitors.
    Morise T; Takeuchi Y; Okamoto S; Takeda R
    Biochem Biophys Res Commun; 1991 Apr; 176(2):875-81. PubMed ID: 1851007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hypothalamic lesions on interaction of centrally administered ANF and the circulating sodium-pump inhibitor.
    Songu-Mize E; Bealer SL
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S4-6. PubMed ID: 7508025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Na+,K+,2Cl-cotransport system in HeLa cells: aspects of its physiological regulation.
    Kort JJ; Koch G
    J Cell Physiol; 1990 Nov; 145(2):253-61. PubMed ID: 2174063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of a Na+/K+ ATPase inhibitor from borderline hypertensives' plasma.
    Boschi S; Borghi C; Munarini A; Costa FV; Lu ZR; deVries D; Ambrosioni E
    Biochem Biophys Res Commun; 1990 Jun; 169(2):360-8. PubMed ID: 2162662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of synthetic atrial natriuretic factor on rubidium uptake by human erythrocytes.
    Hernando N; Caramelo C; Tejedor A; Fernandez-Cruz A; López-Novoa JM
    Biochem Biophys Res Commun; 1985 Aug; 130(3):1066-71. PubMed ID: 2992497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for the sodium, potassium adenosine triphosphatase (Na+,K+ ATPase) enzyme in degranulation of rat basophilic leukaemia cells.
    Gentile DA; Skoner DP
    Clin Exp Allergy; 1996 Dec; 26(12):1449-60. PubMed ID: 9027446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Na+/K+-ATPase inhibitors: effects of neuropeptides, volume expansion and salt loading in conscious rats.
    Schmitt BM; Unger T; Rettig R
    Clin Exp Pharmacol Physiol; 1997 Feb; 24(2):131-8. PubMed ID: 9075584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.
    Correa AH; Choi MR; Gironacci M; Valera MS; Fernández BE
    Regul Pept; 2007 Jan; 138(1):26-31. PubMed ID: 17005263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Centrally administered ANF promotes appearance of a circulating sodium pump inhibitor.
    Songu-Mize E; Bealer SL; Hassid AI
    Am J Physiol; 1990 Jun; 258(6 Pt 2):H1655-9. PubMed ID: 2163216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [(NA++K+)-ATPase inhibitor from bovine hypothalamus].
    Fu Y
    Zhonghua Yi Xue Za Zhi; 1990 Aug; 70(8):442-5, 32. PubMed ID: 2174283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of aluminum and ouabain on synaptosomal choline uptake, acetylcholine release and (Na+/K+)ATPase.
    Silva VS; Nunes MA; Cordeiro JM; Calejo AI; Santos S; Neves P; Sykes A; Morgado F; Dunant Y; Gonçalves PP
    Toxicology; 2007 Jul; 236(3):158-77. PubMed ID: 17560001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.